← Evidence map

ArticlePrzeglad gastroenterologiczny2022

Haloperidol as a treatment option in cannabinoid hyperemesis syndrome.

Peter Stawinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 36514445